This company has been marked as potentially delisted and may not be actively trading. Blue Water Acquisition Corp. III (BLUW) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesShort InterestTrendsBuy This Stock BLUW vs. PRME, PLX, IKT, IZTC, CVM, ZIVO, CRTX, JATT, ALVR, and FNCHShould you be buying Blue Water Acquisition Corp. III stock or one of its competitors? The main competitors of Blue Water Acquisition Corp. III include Prime Medicine (PRME), Protalix BioTherapeutics (PLX), Inhibikase Therapeutics (IKT), Invizyne Technologies (IZTC), CEL-SCI (CVM), ZIVO Bioscience (ZIVO), Cortexyme (CRTX), JATT Acquisition (JATT), AlloVir (ALVR), and Finch Therapeutics Group (FNCH). These companies are all part of the "medical" sector. Blue Water Acquisition Corp. III vs. Its Competitors Prime Medicine Protalix BioTherapeutics Inhibikase Therapeutics Invizyne Technologies CEL-SCI ZIVO Bioscience Cortexyme JATT Acquisition AlloVir Finch Therapeutics Group Blue Water Acquisition Corp. III (NASDAQ:BLUW) and Prime Medicine (NYSE:PRME) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings. Which has stronger earnings & valuation, BLUW or PRME? Blue Water Acquisition Corp. III has higher earnings, but lower revenue than Prime Medicine. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBlue Water Acquisition Corp. IIIN/AN/AN/AN/AN/APrime Medicine$4.96M119.49-$198.13M-$1.56-2.82 Is BLUW or PRME more profitable? Blue Water Acquisition Corp. III's return on equity of 0.00% beat Prime Medicine's return on equity.Company Net Margins Return on Equity Return on Assets Blue Water Acquisition Corp. IIIN/A N/A N/A Prime Medicine N/A -107.87%-74.97% Do institutionals & insiders hold more shares of BLUW or PRME? 70.4% of Prime Medicine shares are owned by institutional investors. 22.7% of Prime Medicine shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts rate BLUW or PRME? Prime Medicine has a consensus price target of $8.92, suggesting a potential upside of 102.42%. Given Prime Medicine's stronger consensus rating and higher probable upside, analysts clearly believe Prime Medicine is more favorable than Blue Water Acquisition Corp. III.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Blue Water Acquisition Corp. III 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Prime Medicine 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.75 Does the media refer more to BLUW or PRME? In the previous week, Blue Water Acquisition Corp. III and Blue Water Acquisition Corp. III both had 2 articles in the media. Prime Medicine's average media sentiment score of 0.51 beat Blue Water Acquisition Corp. III's score of 0.00 indicating that Prime Medicine is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Blue Water Acquisition Corp. III 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Prime Medicine 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryPrime Medicine beats Blue Water Acquisition Corp. III on 8 of the 10 factors compared between the two stocks. Get Blue Water Acquisition Corp. III News Delivered to You Automatically Sign up to receive the latest news and ratings for BLUW and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLUW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLUW vs. The Competition Export to ExcelMetricBlue Water Acquisition Corp. IIIBiological Products, Except Diagnostic IndustryMedical SectorNASDAQ ExchangeMarket Cap$280.64M$288.75M$5.72B$10.26BDividend YieldN/AN/A5.72%4.60%P/E RatioN/AN/A75.1026.36Price / SalesN/A429.81498.56167.32Price / CashN/A22.4425.8129.90Price / BookN/A10.7113.236.29Net IncomeN/A-$115.81M$3.28B$270.30M Blue Water Acquisition Corp. III Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLUWBlue Water Acquisition Corp. IIIN/A$9.98flatN/A+3.6%$280.64MN/A0.002News CoveragePRMEPrime Medicine3.3212 of 5 stars$3.89-5.6%$8.92+129.2%-2.0%$523.49M$4.96M-1.90234PLXProtalix BioTherapeutics2.3351 of 5 stars$1.69-1.7%$15.00+787.6%+81.9%$134.75M$61.95M-13.00200IKTInhibikase Therapeutics1.3458 of 5 stars$1.54-7.8%$6.50+322.1%+35.6%$114.76MN/A-0.586IZTCInvizyne TechnologiesN/A$11.76-2.0%N/AN/A$73.52MN/A0.0029Gap UpCVMCEL-SCI1.3548 of 5 stars$9.68-9.4%N/A-74.3%$66.62MN/A-20.1743Positive NewsShort Interest ↓ZIVOZIVO Bioscience0.3459 of 5 stars$14.01+3.8%N/A+10.9%$53.48M$15.85K-2.8710Gap UpCRTXCortexymeN/A$1.61+2.5%N/A+117.7%$48.54MN/A-0.5455JATTJATT AcquisitionN/A$2.20-0.5%N/A-45.9%$37.95MN/A0.003High Trading VolumeALVRAlloVirN/A$4.68+0.9%N/A-77.5%$23.60MN/A-0.23110Gap DownHigh Trading VolumeFNCHFinch Therapeutics Group1.3961 of 5 stars$12.67-0.2%N/A+9.7%$20.35MN/A-1.44190Positive NewsShort Interest ↓Gap Down Related Companies and Tools Related Companies PRME Competitors PLX Competitors IKT Competitors IZTC Competitors CVM Competitors ZIVO Competitors CRTX Competitors JATT Competitors ALVR Competitors FNCH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLUW) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored“Godfather of AI’s” dire warningAI pioneer Geoffrey Hinton warns the technology could create massive unemployment and widen inequality, but Po...Porter & Company | SponsoredAmerica’s most terrifying chart?MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored(Please Ignore if Already Rich)Discover how to get access to a weekly livestream with TWO Pro Traders for a full month… And learn their un...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Blue Water Acquisition Corp. III Please log in to your account or sign up in order to add this asset to your watchlist. Share Blue Water Acquisition Corp. III With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BLUW Stock Alerts